Similar articles

• The use of doxepin in the treatment of symptoms of anxiety neurosis and accompanying depression: a collaborative controlled study.

  Goldberg HL, Finnery RJ. Goldberg HL, et al. Am J Psychiatry. 1972 Jul;129(1):74-7. doi: 10.1176/ajp.129.1.74. Am J Psychiatry. 1972. PMID: 4556088 Clinical Trial. No abstract available.
• [Double-blind clinical study with a new psychotropic agent: doxepin versus placebo].

  Hollanda Júnior L, da Silva CN, Lira BS, Ferreira SC. Hollanda Júnior L, et al. Hospital (Rio J). 1970 Mar;77(3):799-803. Hospital (Rio J). 1970. PMID: 4936362 Clinical Trial. Portuguese. No abstract available.
• [Comparative evaluation of antidepressive-anxiolytic substances, with special references to Doxepin (Sinquan), a diphenylmethane derivative].

  Terzani S. Terzani S. Schweiz Arch Neurol Neurochir Psychiatr. 1972;110(1):169-82. Schweiz Arch Neurol Neurochir Psychiatr. 1972. PMID: 5028388 German. No abstract available.
• Pharmacotherapy of tension and anxiety.

  Lehmann HE, Ban TA. Lehmann HE, et al. Curr Psychiatr Ther. 1972;12:70-80. Curr Psychiatr Ther. 1972. PMID: 4555859 Review. No abstract available.
• The mousetrap: managing the placebo effect in antidepressant trials.

  Lakoff A. Lakoff A. Mol Interv. 2002 Apr;2(2):72-6. doi: 10.1124/mi.2.2.72. Mol Interv. 2002. PMID: 14993352 Review. No abstract available.